metricas
covid
Buscar en
Clinics
Toda la web
Inicio Clinics Pelvic congestion syndrome as a differential diagnosis of chronic pelvic pain in...
Journal Information
Vol. 79. (In progress)
(January - December 2024)
Share
Share
Download PDF
More article options
Vol. 79. (In progress)
(January - December 2024)
Editorials
Full text access
Pelvic congestion syndrome as a differential diagnosis of chronic pelvic pain in women
Visits
18
Marcos de Lorenzo Messinaa,*, Pedro Puech-Leãob, Ricardo dos Santos Simõesa,b,
Corresponding author
ricardo.simoes@hc.fm.usp.br

Corresponding author.
, Maria Cândida Pinheiro Baracata, José Maria Soares Júniora, Edmund Chada Baracata,b
a Gynecology Division, Obstetrics and Gynecology Department, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
b Vascular Surgery Division, Surgery Department, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

Chronic Pelvic Pain (CPP) is a symptom reported by many women during gynecologist visits and whose cause often remains unknown. According to the Centers for Disease Control and Prevention of the USA (CDC), CPP accounts for nearly 9% of all appointments to gynecologists. Moreover, CPP is responsible for 20%‒30% of all laparoscopies in adults.1,2

Among the differential diagnoses (endometriosis, adenomyosis, pelvic inflammatory disease, adhesions, urological, gastrointestinal, musculoskeletal causes, among others), Pelvic Venous Congestion Syndrome (PVCS) might be perhaps the least considered. However, PVCS may account for one-third of the real causes of CPP in women during the evaluation after all other causes of pain have been excluded.2

PVCS is defined as the presence of tortuous or congested ovarian or pelvic veins associated with CPP, in addition to a sensation of pressure and heaviness in the hypogastrium. The pain typically worsens during the premenstrual period, after long periods in the orthostasis position, and after sexual intercourse, whereas its association with varicose veins of the vulva and lower limbs is not uncommon.3

The pathophysiology of PVCS is not yet fully understood, but it is known that common causes of varicosities in other regions also play a role in the female pelvic region, such as valve incompetence, blood reflux, and venous engorgement. In addition, ovarian hormonal dysfunction has been suggested to play an important role, since estrogen is known to act as a venous vasodilator.4

The anatomy of the venous drainage of the female pelvis may interfere with the pelvic vein dilatation The left ovarian vein flows into the ipsilateral renal vein at a 90° angle, unlike the opening of the right ovarian vein into the inferior vena cava (at an acute angle), which may justify findings of larger venous diameters on the left. Venous compressions leading to stasis such as May-Thurner and/or Nutcracker syndrome also contribute to the etiology of pelvic congestion.4

Venography is the gold standard for diagnosing PVCS, as it allows us to identify tortuosities and treat them with angioplasty and/or embolization at the same time. Other less invasive exams are considered in the diagnostic workup, such as angioresonance, angiotomography, and ultrasound, as well as laparoscopy.2 Ultrasonography is the least expensive exam for screening and is often one of the first exams requested in the investigation of gynecological conditions that cause CPP.5

The diagnosis of pelvic venous congestion syndrome is based on a combination of signs and symptoms, physical examination, and documentation of dilated vessels or pelvic vein incompetence, after excluding other causes. Although the absence of pelvic venous changes helps to exclude PVCS, the presence of these abnormalities is not a diagnostic criterion. Findings of venous dilation on imaging tests must be carefully evaluated and associated with a suggestive clinical picture for diagnostic elucidation.4

Clinical treatment is conflicting and lacks scientific evidence. The use of progestogen is discussed in several publications, with medroxyprogesterone acetate showing significant improvement when compared to placebo in up to 9 months of follow-up.6,7 GnRH analog, a blocker of the hypothalamic-pituitary-ovarian axis, can be used for a period of up to 6 months and promotes improvement in CPP at rates higher than medroxyprogesterone acetate. However, the side effects of that drug including depression, anxiety, and sexual dysfunctions can impair the effectiveness in controlling CPP as well as the adherence of treatment.8

Regarding surgical treatment, laparoscopic ligation of the gonadal veins was initially suggested as a form of PVCS treatment. However, the complex hemodynamic process involved in PVCS cannot always be resolved by surgical ligation of the ovarian veins. Also, higher recurrence rates of venous disorders were characterized when comparing conventional laparoscopic ligation with endovascular alternatives.

Finally, hysterectomy does not present scientific evidence of improvement in CPP secondary to PVCS and its indication should be discouraged.9 According to literature evidence, endovascular techniques such as iliac and renal angioplasty and gonadal vein embolization have been considered the best alternative in the current scientific scenario and further research is necessary in the field.4,9

Author's contribution

All authors contributed equally to the conceptualization, writing, and reviewing of the present manuscript.

References
[1]
Dydyk AM, Gupta N. Chronic pelvic pain. [Updated 2023 Apr 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan- https://www.ncbi.nlm.nih.gov/books/NBK554585/.
[2]
L Gibran, BMM Gonçalves, EC Baracat, JM Soares Jr.
The challenges of female chronic pelvic pain.
Rev Assoc Med Bras, 70 (2024), pp. e706EDIT
[3]
A Jurga-Karwacka, GM Karwacki, A Schoetzau, CJ Zech, V Heinzelmann-Schwarz, FD Schwab.
A forgotten disease: pelvic congestion syndrome as a cause of chronic lower abdominal pain.
PLoS One, 14 (2019),
[4]
R Champaneria, L Shah, J Moss, JK Gupta, J Birch, LJ Middleton, et al.
The relationship between pelvic vein incompetence and chronic pelvic pain in women: systematic reviews of diagnosis an treatment effectiveness.
Health Technol Assess, 20 (2016), pp. 1-108
[5]
SJ Park, JW Lim, YT Ko, DH Lee, Y Yoon, JH Oh, et al.
Diagnosis of pelvic congestion syndrome using transabdominal and transvaginal sonography.
AJR Am J Roentgenol, 182 (2004), pp. 683-688
[6]
CM Farquhar, V Rogers, S Franks, S Pearce, J Wadsworth, RW. Beard.
A randomized controlledtrial of medroxyprogesterone acetate and psychotherapy for the treatment of pelvic congestion.
Br J Obstet Gynaecol, 96 (1989), pp. 1153-1162
[7]
T Shokeir, M Amr, M. Abdelshaheed.
The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study.
Arch Gynecol Obstet, 280 (2009), pp. 437-443
[8]
SM Alshehre, S Duffy, G Jones, WL Ledger, M. Metwally.
A prospective, single-centre, single-arm, open label study of the long-term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain.
Reprod Biol Endocrinol, 18 (2020), pp. 28
[9]
PL Antignani, Z Lazarashvili, JL Monedero, SZ Ezpeleta, MS Whiteley, NM Khilnani, et al.
Diagnosis and treatment of pelvic congestion syndrome: UIP consensus document.
Int Angiol, 38 (2019), pp. 265-283
Copyright © 2024. HCFMUSP
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.clinsp.2023.100310
No mostrar más